HealthEquity Reports Record HSA Sales, Asset Growth
The total number of HSAs as of
“Team Purple finished fiscal 2023 with record sales of nearly 1 million new HSAs and with
Also commenting,
Total Accounts (unaudited)
| (in thousands, except percentages) | % Change | |||||
| HSAs | 7,984 | 7,207 | 11 | % | ||
| New HSAs from sales - Quarter-to-date | 445 | 472 | (6 | )% | ||
| New HSAs from sales - Year-to-date | 971 | 918 | 6 | % | ||
| New HSAs from acquisitions - Year-to-date | 90 | 740 | (88 | )% | ||
| HSAs with investments | 541 | 455 | 19 | % | ||
| CDBs | 6,933 | 7,192 | (4 | )% | ||
| Total Accounts | 14,917 | 14,399 | 4 | % | ||
| Average Total Accounts - Quarter-to-date | 14,677 | 14,326 | 2 | % | ||
| Average Total Accounts - Year-to-date | 14,531 | 13,450 | 8 | % | ||
HSA Assets (unaudited)
| (in millions, except percentages) | % Change | |||||||
| HSA cash | $ | 14,199 | $ | 12,943 | 10 | % | ||
| HSA investments | 7,947 | 6,675 | 19 | % | ||||
| Total HSA Assets | 22,146 | 19,618 | 13 | % | ||||
| Average daily HSA cash with yield - Year-to-date | 13,049 | 10,579 | 23 | % | ||||
| Average daily HSA cash with yield - Quarter-to-date | 13,375 | 12,118 | 10 | % | ||||
In previous years, the Company provided its initial business outlook for the following fiscal year in connection with reporting its sales results in February. With the Company providing its initial business outlook for fiscal year 2024 in its third quarter earnings report in December and fiscal 2023 sales results in line with previously provided estimates, the Company will not be hosting an investor call today, but its management team plans to present and meet with investors at the following upcoming investor conferences:
BTIG Virtual Medtech,
| Date: | ||
| Location: | ||
| Time: | Scheduled one-on-one meetings | |
| Webcast: | None |
Baird’s Silicon Slopes Event
| Date: | ||
| Location: | Waldorf Astoria Park City | |
| Time: | ||
| Webcast: | None |
| Date: | ||
| Location: | ||
| Time: | ||
| Webcast: | None |
Non-GAAP financial information
Our previously provided guidance for fiscal year 2023 includes certain non-GAAP financial measures, including Adjusted EBITDA, non-GAAP net income, and non-GAAP net income per diluted share, to supplement our financial information presented on a GAAP basis. For definitions of these non-GAAP measures, as well as reconciliations of the applicable non-GAAP financial measures to the most closely applicable GAAP financial measures, see our press release issued on
About HealthEquity
Forward-looking statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “aims,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.
Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following:
- the impact of societal and economic changes arising out of the COVID-19 pandemic on the Company, its operations and its financial results;
- our ability to realize the anticipated financial and other benefits from combining the operations of recent and future acquisitions with our business successfully;
- our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry;
- our dependence on the continued availability and benefits of tax-advantaged health savings accounts and other consumer-directed benefits;
- our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;
- the significant competition we face and may face in the future, including from those with greater resources than us;
- our reliance on the availability and performance of our technology and communications systems;
- potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business;
- the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;
- our ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser and other laws applicable to our business;
- our reliance on partners and third-party vendors for distribution and important services;
- our ability to develop and implement updated features for our technology and communications systems and successfully manage our growth;
- our ability to protect our brand and other intellectual property rights; and
- our reliance on our management team and key team members.
For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the
Investor Relations Contact
801-727-1209
[email protected]
Certain terms
| Term | Definition |
| HSA | A financial account through which consumers spend and save long-term for healthcare on a tax-advantaged basis. |
| CDB | Consumer-directed benefits offered by employers, including flexible spending and health reimbursement arrangements (“FSAs” and “HRAs”), Consolidated Omnibus Budget Reconciliation Act (“COBRA”) administration, commuter and other benefits. |
| HSA member | Consumers with HSAs that we serve. |
| Total HSA Assets | HSA members’ custodial cash assets held by our federally insured depository partners and our insurance company partners. Total HSA Assets also includes HSA members' investments in mutual funds through our custodial investment fund partner. |
| Total Accounts | The sum of HSAs and CDBs on our platforms. |
Source: HealthEquity, Inc.